Combination Therapy with Copanlisib and Niraparib in Patients with Recurrent Endometrial and Ovarian Cancer (COPANIRA): Efficacy, Toxicity, and Translational Insights

Allison L. Brodsky(The University of Texas MD Anderson Cancer Center), Shannon N. Westin(The University of Texas MD Anderson Cancer Center)
Clinical Cancer Research
January 13, 2026
Cited by 0


Related Papers

No related papers found

Powered by citation graph analysis